Janus Henderson Horizon Biotechnology Fund IU2 EUR
LU2441282626
Janus Henderson Horizon Biotechnology Fund IU2 EUR/ LU2441282626 /
| NAV2024-11-15 |
Chg.-1.0900 |
Type of yield |
Investment Focus |
Investment company |
| 23.3400EUR |
-4.46% |
reinvestment |
Equity
Worldwide
|
Janus Henderson Inv. ▶ |
Investment strategy
The Fund aims to provide capital growth over the long term.
The Fund invests at least 80% of its assets in shares (equities) and equity-related securities of companies, which are biotechnology or biotechnology-related, of any size, including smaller capitalisation companies, in any country. The Fund may also invest in other assets including bonds (including convertible bonds), preference shares, cash and money market instruments. The Investment Manager may use derivatives (complex financial instruments) with the aim of making investment gains in line with the Fund's objective, to reduce risk or to manage the Fund more efficiently.
Investment goal
The Fund aims to provide capital growth over the long term.
Master data
| Type of yield: |
reinvestment |
| Funds Category: |
Equity |
| Region: |
Worldwide |
| Branch: |
Sector Biotechnology |
| Benchmark: |
NASDAQ Biotechnology Total Return Index |
| Business year start: |
07-01 |
| Last Distribution: |
- |
| Depository bank: |
BNP Paribas Securities Services, Niederlassung Luxemburg |
| Fund domicile: |
Luxembourg |
| Distribution permission: |
Austria, Germany, Switzerland, Czech Republic |
| Fund manager: |
Andy Acker, Daniel Lyons, Agustin Mohedas |
| Fund volume: |
395 mill.
USD
|
| Launch date: |
2022-02-25 |
| Investment focus: |
- |
Conditions
| Issue surcharge: |
5.00% |
| Max. Administration Fee: |
0.90% |
| Minimum investment: |
1,000,000.00 EUR |
| Deposit fees: |
0.65% |
| Redemption charge: |
1.00% |
| Key Investor Information: |
- |
Investment company
| Funds company: |
Janus Henderson Inv. |
| Address: |
201 Bishopsgate, EC2M 3AE, London |
| Country: |
United Kingdom |
| Internet: |
www.janushenderson.com/
|
Assets
| Stocks |
|
96.74% |
| Bonds |
|
1.80% |
| Cash |
|
1.46% |
Countries
| United States of America |
|
72.65% |
| Netherlands |
|
4.79% |
| United Kingdom |
|
3.67% |
| Ireland |
|
3.13% |
| Denmark |
|
2.35% |
| France |
|
1.99% |
| Virgin Islands (British) |
|
1.91% |
| Cayman Islands |
|
1.76% |
| China |
|
1.55% |
| Cash |
|
1.46% |
| Canada |
|
0.61% |
| Others |
|
4.13% |
Branches
| Pharma/Biotechnology |
|
90.87% |
| Cash |
|
1.46% |
| Healthcare services |
|
1.00% |
| Healthcare appliances |
|
0.74% |
| Others |
|
5.93% |
